Initial combination therapy with irbesartan/hydrochlorothiazide for hypertension: an analysis of the relationship between baseline blood pressure and the need for combination therapy.

Initial combination therapy with irbesartan/hydrochlorothiazide for hypertension: an analysis of the relationship between baseline blood pressure and the need for combination therapy. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Initial combination therapy with irbesartan/hydrochlorothiazide for hypertension: an analysis of the relationship between baseline blood pressure and the need for combination therapy. Abstract Text:

Stanley Franklin,Pablo Lapuerta,David Cox,Mark Donovan,Stanley Franklin,Pablo Lapuerta,David Cox,Mark Donovan,Stanley Franklin,Pablo Lapuerta,David Cox,Mark Donovan,

Hypertension treatment guidelines recommend initiating 2-drug therapy whenever blood pressure (BP) is >/=20 mm Hg systolic or >/=10 mm Hg diastolic above goal. This post hoc pooled analysis of 2 multicenter, randomized, double-blind, active-controlled forced-titration studies in 1235 patients with moderate and severe hypertension examined how baseline BP levels relate to the need for combination therapy by comparing the antihypertensive efficacy and tolerability of once-daily fixed-dose irbesartan/hydrochlorothiazide (HCTZ) 300/25 mg compared with irbesartan 300-mg or HCTZ 25-mg monotherapies. In study 1, patients with severe hypertension (seated diastolic BP [SeDBP] >/=110 mm Hg) were treated for 7 weeks with irbesartan or irbesartan/HCTZ combination therapy, with forced-titration after week 1. In study 2, patients with moderate hypertension (seated systolic BP [SeSBP] 160-180 mm Hg or SeDBP 100-110 mm Hg) were treated for 12 weeks with irbesartan/HCTZ, irbesartan monotherapy, or HCTZ monotherapy, with forced-titration after week 2. The relationship between baseline BP and the likelihood of achieving BP goals (SeSBP <140 mm Hg or SeDBP <90 mm Hg; SeSBP <130 mm Hg or SeDBP <80 mm Hg) as well as the antihypertensive response was evaluated at week 7/8. The need for combination therapy increased with increasing baseline BP and lower BP goals across the range of BP levels studied, with a comparable adverse effect profile to monotherapy. These results suggest that the likelihood of achieving an early BP goal for a given BP severity should be considered when choosing initial combination therapy vs monotherapy. (J Clin Hypertens. 2007;9(12 suppl 5):15-22).

Initial combination therapy with irbesartan/hydrochlorothiazide for hypertension: an analysis of the relationship between baseline blood pressure and the need for combination therapy. Publishing Authors By Initials

S Franklin,P Lapuerta,D Cox,M Donovan,S Franklin,P Lapuerta,D Cox,M Donovan,S Franklin,P Lapuerta,D Cox,M Donovan,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Initial combination therapy with irbesartan/hydrochlorothiazide for hypertension: an analysis of the relationship between baseline blood pressure and the need for combination therapy. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Journal of clinical hypertension (Greenwich, Conn.

VOLUME: 9

Page Numbers: 15-22

Journal Abbreviation:

ISSN: 1524-6175

DAY: 29

MONTH: Dec

YEAR: 2007

Initial combination therapy with irbesartan/hydrochlorothiazide for hypertension: an analysis of the relationship between baseline blood pressure and the need for combination therapy. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 100888554

Initial combination therapy with irbesartan/hydrochlorothiazide for hypertension: an analysis of the relationship between baseline blood pressure and the need for combination therapy. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Initial combination therapy with irbesartan/hydrochlorothiazide for hypertension: an analysis of the relationship between baseline blood pressure and the need for combination therapy. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Initial combination therapy with irbesartan/hydrochlorothiazide for hypertension: an analysis of the relationship between baseline blood pressure and the need for combination therapy.

AFFILIATION: From the University of California, Irvine, CA; and Bristol-Myers Squibb, Princeton, NJ.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Clin Hypertens (Greenwich)

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Initial combination therapy with irbesartan/hydrochlorothiazide for hypertension: an analysis of the relationship between baseline blood pressure and the need for combination therapy Related Publications

• A patient-centered approach to developing a comprehensive symptom and quality of life assessment of anal incontinence.
• A study of the use of phenothiazine derivatives.
• AIDS: focus on youth.
• Abdominal surgery in infancy and childhood.
• Adolescent alcohol initiation: a review of psychosocial risk factors.
• Alcohol and violence: comparison of the psychosocial correlates of adolescent involvement in alcohol-related physical fighting versus other physical fighting.
• Antiemetic Use in Acetaminophen Poisoning: How Does the Route of N-acetylcysteine Administration Affect Utilization?
• COMMENTARY. restoration of an intruded maxillary central incisor with a uniquely designed dowel and core restoration: a case report.
• Calcified cyst of spleen.
• Effect of a short-term fast on intestinal disaccharidase activity and villus morphology of piglets suckling insulin-like growth factor-I transgenic sows.
• Establishing normal reference ranges for prostate volume change with age in the population-based Krimpen-study: Prediction of future prostate volume in individual men.
• Further validation of the alcohol dependence scale as an index of severity.
• Hypoglycemic detection at the portal vein is mediated by capsaicin-sensitive primary sensory neurons.
• Identifying genes differentially expressed between PGCs and ES cells reveals a role for CREB-binding protein in germ cell survival.
• Initial combination therapy with irbesartan/hydrochlorothiazide for hypertension: an analysis of the relationship between baseline blood pressure and the need for combination therapy.
• Letter to the editor. Problem based learning in undergraduate dental education : faculty development at the University of Southern California School of Dentistry.
• Low risk research using routinely collected identifiable health information without informed consent: encounters with the Patient Information Advisory Group.
• Megacystis-microcolon-intestinal hypoperistalsis syndrome: a new cause of intestinal obstruction in the newborn. Report of radiologic findings in five newborn girls.
• Observation of three weakly bound valence states of I2.
• Portal vein hypoglycemia is essential for full induction of hypoglycemia-associated autonomic failure with slow-onset hypoglycemia.
• Psychosocial correlates of marijuana use and problem drinking in a national sample of adolescents.
• Public (Mis)understanding of the UV Index.
• Really underage drinkers: the epidemiology of children's alcohol use in the United States.
• Role of organic cation transporters in dopamine uptake across olfactory and nasal respiratory tissues.
• The bladder in paraplegia.
• The influence of spray properties on intranasal deposition.
• The use of dihydroxyphenylisatin in cholecystography.
• Wedge osteotomy of the neck of the femur in advanced cases of displaced upper femoral epiphysis; 10 year study.
• Who am I supposed to believe?
• [Not Available.]